Literature DB >> 19038766

The cell of origin of ovarian epithelial tumours.

Louis Dubeau1.   

Abstract

Although it is widely believed that ovarian epithelial tumours arise in the coelomic epithelium that covers the ovarian surface, it has been suggested that they could instead arise from tissues that are embryologically derived from the Müllerian ducts. This article revisits this debate by discussing recent epidemiological and molecular biological findings as well as evidence based on histopathological observations of surgical specimens from individuals with familial ovarian cancer predisposition. Morphological, embryological, and molecular biological characteristics of ovarian epithelial tumours that must be accounted for in formulating a theory about their cell of origin are reviewed, followed by comments about the ability of these two hypotheses to account for each of these characteristics. An argument is made that primary ovarian epithelial tumours, fallopian tube carcinomas, and primary peritoneal carcinomas are all Müllerian in nature and could therefore be regarded as a single disease entity. Although a substantial proportion of cancers currently regarded as of primary ovarian origin arise in the fimbriated end of the fallopian tube, this site cannot account for all of these tumours, some of which are most likely derived from components of the secondary Müllerian system.

Entities:  

Mesh:

Year:  2008        PMID: 19038766      PMCID: PMC4176875          DOI: 10.1016/S1470-2045(08)70308-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  42 in total

1.  Pathologic findings in prophylactic oophorectomy specimens in high-risk women.

Authors:  Katherine Leeper; Rochelle Garcia; Elizabeth Swisher; Barbara Goff; Benjamin Greer; Pamela Paley
Journal:  Gynecol Oncol       Date:  2002-10       Impact factor: 5.482

Review 2.  The distal fallopian tube: a new model for pelvic serous carcinogenesis.

Authors:  Christopher P Crum; Ronny Drapkin; Alexander Miron; Tan A Ince; Michael Muto; David W Kindelberger; Yonghee Lee
Journal:  Curr Opin Obstet Gynecol       Date:  2007-02       Impact factor: 1.927

3.  Does the rete ovarii act as a trigger for the onset of meiosis?

Authors:  A G Byskov
Journal:  Nature       Date:  1974-11-29       Impact factor: 49.962

4.  Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

Authors:  Amy Finch; Mario Beiner; Jan Lubinski; Henry T Lynch; Pal Moller; Barry Rosen; Joan Murphy; Parviz Ghadirian; Eitan Friedman; William D Foulkes; Charmaine Kim-Sing; Teresa Wagner; Nadine Tung; Fergus Couch; Dominique Stoppa-Lyonnet; Peter Ainsworth; Mary Daly; Babara Pasini; Ruth Gershoni-Baruch; Charis Eng; Olufunmilayo I Olopade; Jane McLennan; Beth Karlan; Jeffrey Weitzel; Ping Sun; Steven A Narod
Journal:  JAMA       Date:  2006-07-12       Impact factor: 56.272

5.  Tubal ligation and fatal ovarian cancer in a large prospective cohort study.

Authors:  H L Miracle-McMahill; E E Calle; A S Kosinski; C Rodriguez; P A Wingo; M J Thun; C W Heath
Journal:  Am J Epidemiol       Date:  1997-02-15       Impact factor: 4.897

Review 6.  Possible role of ovarian epithelial inflammation in ovarian cancer.

Authors:  R B Ness; C Cottreau
Journal:  J Natl Cancer Inst       Date:  1999-09-01       Impact factor: 13.506

7.  Cysts (cystadenomas) and tumors of the rete ovarii.

Authors:  J L Rutgers; R E Scully
Journal:  Int J Gynecol Pathol       Date:  1988       Impact factor: 2.762

8.  Müllerian-inhibiting substance function during mammalian sexual development.

Authors:  R R Behringer; M J Finegold; R L Cate
Journal:  Cell       Date:  1994-11-04       Impact factor: 41.582

9.  Multiple focal extraovarian serous carcinoma.

Authors:  C Z August; T M Murad; M Newton
Journal:  Int J Gynecol Pathol       Date:  1985       Impact factor: 2.762

10.  Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study.

Authors:  S E Hankinson; D J Hunter; G A Colditz; W C Willett; M J Stampfer; B Rosner; C H Hennekens; F E Speizer
Journal:  JAMA       Date:  1993-12-15       Impact factor: 56.272

View more
  140 in total

1.  Ovarian surface epitheliectomy in the non-human primate: continued cyclic ovarian function and limited epithelial replacement.

Authors:  Jay W Wright; Tanja Pejovic; Leigh Jurevic; Cecily V Bishop; Theodore Hobbs; Richard L Stouffer
Journal:  Hum Reprod       Date:  2011-03-18       Impact factor: 6.918

2.  Preventing ovarian cancer by salpingectomy.

Authors:  W D Foulkes
Journal:  Curr Oncol       Date:  2013-06       Impact factor: 3.677

3.  Follicle Depletion Provides a Permissive Environment for Ovarian Carcinogenesis.

Authors:  Ying Wang; Kathy Qi Cai; Elizabeth R Smith; Toni M Yeasky; Robert Moore; Parvin Ganjei-Azar; Andres J Klein-Szanto; Andrew K Godwin; Thomas C Hamilton; Xiang-Xi Xu
Journal:  Mol Cell Biol       Date:  2016-08-26       Impact factor: 4.272

4.  Hydrosalpinx as a Rare Presentation of Synchronous Ovarian and Endometrial Carcinoma - A Case Report.

Authors:  Mahjabeen Khan; Sapna Vinit Amin; Sujatha Bagepalli Srinivas; Roopa Padavagodu Shivananda; Navin Patil
Journal:  J Clin Diagn Res       Date:  2016-07-01

Review 5.  The mammalian ovary from genesis to revelation.

Authors:  Mark A Edson; Ankur K Nagaraja; Martin M Matzuk
Journal:  Endocr Rev       Date:  2009-09-23       Impact factor: 19.871

6.  The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube.

Authors:  Wa Xian; Alexander Miron; Michael Roh; Dana R Semmel; Yosuf Yassin; Judy Garber; Esther Oliva; Annekathryn Goodman; Karishma Mehra; Ross S Berkowitz; Christopher P Crum; Bradley J Quade
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

7.  Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis.

Authors:  Mijung Kwon; Soo Jin Lee; Yarong Wang; Yevangelina Rybak; Alex Luna; Srilakshmi Reddy; Asha Adem; Brian T Beaty; John S Condeelis; Steven K Libutti
Journal:  Int J Cancer       Date:  2014-02-20       Impact factor: 7.396

8.  Human ovarian cancer stroma contains luteinized theca cells harboring tumor suppressor gene GT198 mutations.

Authors:  Min Peng; Hao Zhang; Lahcen Jaafar; John I Risinger; Shuang Huang; Nahid F Mivechi; Lan Ko
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

Review 9.  Pathogenesis of ovarian cancer: clues from selected overexpressed genes.

Authors:  Ie-Ming Shih; Ben Davidson
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

10.  In-depth LC-MS/MS analysis of the chicken ovarian cancer proteome reveals conserved and novel differentially regulated proteins in humans.

Authors:  Angelito I Nepomuceno; Huanjie Shao; Kai Jing; Yibao Ma; James N Petitte; Michael O Idowu; David C Muddiman; Xianjun Fang; Adam M Hawkridge
Journal:  Anal Bioanal Chem       Date:  2015-07-10       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.